Core Viewpoint - The company, Shanxi Panlong Pharmaceutical Group Co., Ltd., is revising its Articles of Association and related corporate governance systems to enhance governance efficiency and streamline management processes, including the abolition of the supervisory board and the transfer of its responsibilities to the audit committee of the board of directors [1][2][3]. Summary by Sections Revision of Articles of Association - The company plans to amend its Articles of Association to comply with the latest regulatory framework and improve governance effectiveness [1][2]. - The supervisory board will be dissolved, and its functions will be transferred to the audit committee, pending approval from the shareholders' meeting [1][2]. Specific Amendments - The amendments will include changes to the roles and responsibilities of the board of directors and the legal representative of the company [4][5]. - The new provisions will clarify that the legal representative's civil activities will be the company's responsibility, and the company can seek compensation from the legal representative if damages occur due to their duties [4][5]. Governance Structure Changes - The supervisory board's responsibilities will cease upon the approval of the revised Articles of Association, and the rules governing the supervisory board will be abolished [2][3]. - The company will ensure that the audit committee will diligently perform its supervisory functions until the shareholders' meeting approves the changes [2][3]. Legal Compliance - The revisions are in accordance with the Company Law, Securities Law, and relevant regulations from the Shenzhen Stock Exchange [3][4]. - The company emphasizes that the amendments aim to protect the rights and interests of shareholders, employees, and creditors while ensuring compliance with legal requirements [1][2].

Core Points - The board of directors of Rongxin Education and Cultural Industry Development Co., Ltd. held its eighth meeting of the fourth session on August 26, 2025, to discuss various proposals [1][2][3]. Group 1: Meeting Details - The meeting was convened by Chairwoman Wang Yihua and attended by all 8 directors, with senior management present [1]. - The meeting complied with relevant laws, regulations, and the company's articles of association [1]. Group 2: Resolutions Passed - The board approved the proposal regarding the 2025 semi-annual report and summary, confirming the accuracy and completeness of financial information [2]. - The board also approved a special report on the management and use of raised funds for the first half of 2025, confirming compliance with regulations [2]. - A proposal to amend the company's articles of association was approved, with authorization for management to handle subsequent registration matters [3]. - The board approved the proposal to revise corporate governance-related systems, which will also require shareholder approval [5]. - A proposal to use part of the excess raised funds to permanently supplement working capital was approved, pending shareholder approval [6]. - The board scheduled the second extraordinary general meeting of shareholders for September 15, 2025 [6]. Group 3: Voting Results - All proposals received unanimous support with 8 votes in favor, and no votes against or abstentions [2][3][5][6]. Group 4: Reference Documents - The company disclosed relevant documents on the Giant Tide Information Network, including the meeting resolutions and audit committee decisions [6].

Group 1 - The board of directors of Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. held its third meeting of the fourth session on August 26, 2025, with all seven directors present [1][2] - The board approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's operational status without any false records or omissions [1][2] - The board also approved amendments to the company's articles of association, eliminating the supervisory board and transferring its powers to the audit committee of the board [2][3] Group 2 - The board approved revisions to internal management systems to enhance corporate governance and compliance with relevant laws and regulations [3][4] - A cash dividend distribution plan for the first half of 2025 was proposed, subject to approval at the upcoming shareholder meeting [4][5] - The board scheduled the second extraordinary general meeting of shareholders for September 15, 2025, to discuss the proposed amendments and dividend plan [4][5]

股票代码：002454 公司简称：松芝股份 公告号：2025-036 上海加冷松芝汽车空调股份有限公司 第六届监事会第八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 会第八次会议于2025年8月17日以邮件形式向全体监事发出通知。 路2059号5楼会议室以现场和通讯表决方式召开。 席会议。 司章程的规定。 表决结果：【3】票同意，【0】票反对，【0】票弃权，此项决议通过。 根据《中华人民共和国公司法》、《关于新 <公司法> 配套制度规则实施相 关过渡期安排》、《上市公司章程指引》等相关法律、法规及规范性文件的规定， 公司拟对《上海加冷松芝汽车空调股份有限公司公司章程》中的部分条款进行修 订。监事会认为本次《公司章程》的修订符合有关法律、法规及规范性文件的规 定，充分结合了公司的实际情况，同意将本议案提交股东大会进行审议。 具体内容详见《上海证券报》、《证券时报》及巨潮资讯网 二、监事会会议审议情况 公司2025年半年度报告及摘要的编制和保密程序符合法律、法规、《公司章 程》和公司管理制度的各项规定；本次半年度报告及摘要 ...

Core Viewpoint - Neusoft Group Co., Ltd. has announced the cancellation of its supervisory board and amendments to its articles of association, reflecting a shift in governance structure and an expansion of its business scope to include artificial intelligence services [1][2]. Summary by Sections Cancellation of Supervisory Board - The company will no longer establish a supervisory board, with the powers previously held by the supervisory board being transferred to the audit committee of the board of directors [2][3]. - Relevant rules and regulations concerning the supervisory board will be abolished, and corresponding amendments to the articles of association will be made [2]. Changes in Business Scope - The company plans to expand its business scope to include "artificial intelligence application software development," "artificial intelligence industry application system integration services," and "second-class value-added telecommunications services" [2][3]. - The final business scope will be subject to approval by the market supervision administration [2]. Changes in Registered Capital and Share Quantity - Due to the implementation of the stock option incentive plan for 2024, the number of shares will continue to change [2]. - As of July 2025, the company is in the process of updating its registered capital and share quantity provisions based on feedback from the China Securities Depository and Clearing Corporation [2]. Amendments to Articles of Association - The articles of association will be revised to reflect the cancellation of the supervisory board and the new governance structure [2][3]. - Specific amendments include changes to the rights and responsibilities of shareholders, the board of directors, and the audit committee [2][3].

证券代码：688295 证券简称：中复神鹰 公告编号：2025-030 中复神鹰碳纤维股份有限公司 第二届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 中复神鹰碳纤维股份有限公司（以下简称"公司"）第二届监事会第八次会 议通知于 2025 年 8 月 16 日以电子邮件的方式发出，会议于 2025 年 8 月 26 日在 公司会议室以现场结合通讯方式召开。会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席裴鸿雁主持。会议的召集和召开符合《公司法》 《证券法》 等法律法规以及《公司章程》《监事会议事规则》等相关规定，会议的表决程序 和表决结果合法有效。 二、监事会会议审议情况 会议经全体参会监事充分审议，形成决议如下： （一）审议通过《取消监事会并修订 <公司章程> 的议案》 表决结果：赞成 3 票，反对 0 票，弃权 0 票。 本议案尚需提交公司股东大会审议。 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《中 复神鹰碳纤维股份 ...

证券代码：601518 证券简称：吉林高速 公告编号：临 2025-021 吉林高速公路股份有限公司 关于取消监事会并修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 吉林高速公路股份有限公司（以下简称公司）于2025年8月26日召开第四届 董事会第六次会议、第四届监事会第六次会议，审议通过《关于取消监事会并修 订 <公司章程> 的议案》,该项议案尚需提交公司2025年第二次临时股东大会审议。 具体情况如下： 一、取消监事会的依据 根据《公司法》（2023年修订）的相关规定，结合公司实际情况，公司将不 再设置监事会，监事会的职权由董事会审计委员会行使，《吉林高速公路股份有 限公司监事会议事规则》等监事会相关制度相应废止。 二、《公司章程》修订要点 一是，新增控股股东和实际控制人专节，明确规定控股股东及实际控制人的 职责和义务；二是，新增董事任职资格、职工董事设置、董事和高级管理人员职 务侵权行为的责任承担等条款；三是，完善董事、董事会及专门委员会的要求， 在"董事会"一章中，新增了"独立董事""董事会专门 ...

证券代码：600546 证券简称:山煤国际 公告编号：临 2025-034 号 山煤国际能源集团股份有限公司 关于修订《公司章程》并取消监事会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据新《公司法》、中国证监会《上市公司章程指引》 （2025 年修订）、上海 证券交易所《股票上市规则》 （2025 年 4 月修订）等法律法规和规范性文件，山 煤国际能源集团股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开第 八届董事会第三十二次会议，审议通过《关于修订 <公司章程> 并取消监事会的议 案》，同意对《公司章程》进行修订，同意提请股东大会审议取消监事会，由审 计委员会行使《公司法》规定的监事会职权。 《公司章程》具体修订内容如下： 序 原章程条款 修订后条款 第一条 为维护山煤国际能源集团 第一条 为维护山煤国际能源集团 股份有限公司（以下简称"公司"）、股东 股份有限公司（以下简称"公司"或"本 和债权人的合法权益，规范公司的组织和 公司"）、股东、职工和债权人的合法权 行为，充分发挥中国共产 ...

证券代码：688377 证券简称：迪威尔 公告编号：2025-018 南京迪威尔高端制造股份有限公司 第六届监事会第七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （二）审议通过《关于取消监事会、调整董事会成员、修订 <公司章程> 并办理 工商变更登记的议案》 监事会认为：为符合对上市公司的规范要求，进一步完善公司治理，根据《公司 法》《关于新 <公司法> 配套制度规则实施相关过渡期安排》《上市公司章程指引》 《上海证券交易所科创板股票上市规则》等法律、法规、规范性文件的规定，监事会 同意对《公司章程》中的部分条款进行修订，将不再设置监事会与监事，监事会的职 权由董事会审计委员会行使，同时优化董事会成员结构，公司董事会由 8 名董事组成， 其中独立董事 3 名，职工代表董事 1 名。 监事会认为：根据《公司法》《关于新 <公司法> 配套制度规则实施相关过渡期 安排》《上市公司章程指引》《上海证券交易所科创板股票上市规则》及其他有关法 律、法规和规范性文件等相关规定，结合公司实际业务情况和治理要求，监事会同 ...

Core Points - The company is holding its third extraordinary general meeting of shareholders in 2025 to discuss changes in registered capital, business address, and amendments to the Articles of Association [1][6][10] Group 1: Meeting Procedures - The meeting will ensure the verification of attendees' identities to maintain order and efficiency [1] - Attendees must arrive on time for registration, as latecomers will not be allowed to participate in voting [2] - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to the rules to avoid disrupting proceedings [2][3] Group 2: Agenda and Proposals - The main agenda item is the proposal to change the company's registered capital and business address, as well as to amend the Articles of Association [6][10] - The company plans to increase its total share capital from 105,609,735 shares to 148,049,102 shares, reflecting a capital increase through a stock dividend distribution [6][7] - The new business address will be updated to "No. 20, Yindong Road, Zhangjiang Town, Pudong New District, Shanghai" [8][9] Group 3: Amendments to Articles of Association - The Articles of Association will be revised to reflect the changes in registered capital and business address [9] - Specific amendments include updating the registered capital from RMB 105,609,735 to RMB 148,049,102 and changing the company address accordingly [9]